Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Camdessanché J[au]:

Paraneoplastic neuropathies. Antoine JC et al. Curr Opin Neurol. (2017)

Foreword. Eymard B et al. Rev Neurol (Paris). (2016)

Amyotrophic lateral sclerosis or not: Keys for the diagnosis. Lenglet T et al. Rev Neurol (Paris). (2017)

Search results

Items: 1 to 50 of 99

1.

Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosis.

Laplaud DA, Casey R, Barbin L, Debouverie M, De Sèze J, Brassat D, Wiertlewski S, Brochet B, Pelletier J, Vermersch P, Edan G, Lebrun-Frenay C, Clavelou P, Thouvenot E, Camdessanché JP, Tourbah A, Stankoff B, Al Khedr A, Cabre P, Lubetzki C, Papeix C, Berger E, Heinzlef O, Debroucker T, Moreau T, Gout O, Bourre B, Wahab A, Labauge P, Magy L, Defer G, Guennoc AM, Maubeuge N, Labeyrie C, Patry I, Nifle C, Casez O, Michel L, Rollot F, Leray E, Vukusic S, Foucher Y; SFSEP and OFSEP groups.

Neurology. 2019 Aug 13;93(7):e635-e646. doi: 10.1212/WNL.0000000000007938. Epub 2019 Jul 12.

PMID:
31300547
2.

Relevance of anti-HNK1 antibodies in the management of anti-MAG neuropathies.

Delmont E, Attarian S, Antoine JC, Paul S, Camdessanché JP, Grapperon AM, Brodovich A, Boucraut J.

J Neurol. 2019 Aug;266(8):1973-1979. doi: 10.1007/s00415-019-09367-0. Epub 2019 May 14.

PMID:
31089861
3.

CLIPPERS and its mimics: evaluation of new criteria for the diagnosis of CLIPPERS.

Taieb G, Mulero P, Psimaras D, van Oosten BW, Seebach JD, Marignier R, Pico F, Rigau V, Ueno Y, Duflos C, Fominykh V, Guiraud V, Lebrun-Frénay C, Camdessanché JP, Kerschen P, Ahle G, Téllez N, Rovira A, Hoang-Xuan K, Pelletier J, Labauge P; in cooperation with the French CLIPPERS group.

J Neurol Neurosurg Psychiatry. 2019 Sep;90(9):1027-1038. doi: 10.1136/jnnp-2018-318957. Epub 2019 May 9.

PMID:
31072955
4.

Completing the Immunological Fingerprint by Refractory Proteins: Autoantibody Screening via an Improved Immunoblotting Technique.

Moritz CP, Tholance Y, Rosier C, Reynaud-Federspiel E, Svahn J, Camdessanché JP, Antoine JC.

Proteomics Clin Appl. 2019 Jul;13(4):e1800157. doi: 10.1002/prca.201800157. Epub 2019 Mar 4.

PMID:
30768763
5.

A clinical screening tool for objective and subjective cognitive disorders in multiple sclerosis.

Guilloton L, Camdessanche JP, Latombe D, Neuschwander P, Cantalloube S, Thomas-Anterion C, Mercier B, Roggerone S, Maucort-Boulch D, Roche S, Jacquin-Courtois S; “Cognition-MS” group of the Rhône-Alpes MS network.

Ann Phys Rehabil Med. 2019 Jan 29. pii: S1877-0657(19)30012-0. doi: 10.1016/j.rehab.2018.11.005. [Epub ahead of print]

PMID:
30703524
6.

First clinical inflammatory demyelinating events of the central nervous system in a population aged over 70 years: A multicentre study.

Lavandier N, Bonnan M, Carra-Dallière C, Charif M, Labauge P, Camdessanche JP, Edan G, Naudin A, Brassat D, Ciron J, Clavelou P, Dulau C, Moroso A, Brochet B, Ouallet JC; on behalf Société Francophone de la Sclérose en Plaques (SFSEP).

Mult Scler Relat Disord. 2019 Feb;28:309-312. doi: 10.1016/j.msard.2018.12.016. Epub 2018 Dec 14.

PMID:
30665072
7.

Reducing the risk of misdiagnosis of indirect ELISA by normalizing serum-specific background noise: The example of detecting anti-FGFR3 autoantibodies.

Moritz CP, Tholance Y, Lassablière F, Camdessanché JP, Antoine JC.

J Immunol Methods. 2019 Mar;466:52-56. doi: 10.1016/j.jim.2019.01.004. Epub 2019 Jan 14.

PMID:
30654043
8.

Phrenic Nerve Conduction in Healthy Subjects.

Vincent M, Court-Fortune I, Costes F, Antoine JC, Camdessanché JP.

Muscle Nerve. 2019 Apr;59(4):451-456. doi: 10.1002/mus.26414. Epub 2019 Jan 24.

PMID:
30623462
9.

Diagnostic criteria for amyotrophic lateral sclerosis: A multicentre study of inter-rater variation and sensitivity.

Johnsen B, Pugdahl K, Fuglsang-Frederiksen A, Kollewe K, Paracka L, Dengler R, Camdessanché JP, Nix W, Liguori R, Schofield I, Maderna L, Czell D, Neuwirth C, Weber M, Drory VE, Abraham A, Swash M, de Carvalho M.

Clin Neurophysiol. 2019 Feb;130(2):307-314. doi: 10.1016/j.clinph.2018.11.021. Epub 2018 Dec 9.

PMID:
30573424
10.

Intravenous immunoglobulin for treatment of chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy in France: are daily practices in accordance with guidelines?

Rosier C, Graveline N, Lacour A, Antoine JC, Camdessanché JP.

Eur J Neurol. 2019 Apr;26(4):575-580. doi: 10.1111/ene.13841. Epub 2018 Nov 15.

PMID:
30326184
11.

N-hexane exposure: a cause of small fiber neuropathy.

Guimarães-Costa R, Schoindre Y, Metlaine A, Lefaucheur JP, Camdessanché JP, Maisonobe T, Léger JM.

J Peripher Nerv Syst. 2018 Jun;23(2):143-146. doi: 10.1111/jns.12261. Epub 2018 Mar 26.

PMID:
29542204
12.

Treating asymptomatic bacteriuria before immunosuppressive therapy during multiple sclerosis: Should we do it?

Rouzaud C, Hautecoeur P, Donze C, Heinzlef O, Dinh A; Club Francophone de la Sclérose en Plaque, Creange A, Abdullatif A, Audouin B, Tourbah A, Berger E, Bourre B, Brochet B, Mekies C, Cabre P, Papeix C, Casez O, Brassat D, Defer G, Derache N, De Seze J, Dive D, LePage E, Fromont A, Gouider R, Edan G, Pelletier J, Grimaud J, Guennoc AM, Camdessanché JP, Kwiatkowski A, Laplaud D, Lebrun C, Debouverie M, Coustans M, Gout O, La Rochelle OA, Heinzlef O, Ouallet JC, Cavelou P, Hautecoeur P, Labauge P, Vermersch P, Wiertlewski S, Vukusic S, Marignier R, Schluep M, Seeldrayers P, Slassi I, Stankoff B, Thaite F, Moreau T, Thouvenot E, Zephir H, Ciron J, Collongues N, Kerschen P, Cohen M, Gueguen A, Mathey G, Carra C, Bernady P, Faucheux JM, Planque E, Donze C, Ruet A, Mouzawakh C, Pittion S.

Mult Scler Relat Disord. 2017 Nov;18:161-163. doi: 10.1016/j.msard.2017.08.009. Epub 2017 Aug 24. No abstract available.

PMID:
29141801
13.

Early intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with onconeural antibodies.

Berzero G, Karantoni E, Dehais C, Ducray F, Thomas L, Picard G, Rogemond V, Candelier G, Camdessanché JP, Antoine JC, De Seze J, Liou-Schischmanoff A, Honnorat J, Delattre JY, Psimaras D.

J Neurol Neurosurg Psychiatry. 2018 Jul;89(7):789-792. doi: 10.1136/jnnp-2017-316904. Epub 2017 Oct 30. No abstract available.

14.

Anti-MAG antibodies in 202 patients: clinicopathological and therapeutic features.

Svahn J, Petiot P, Antoine JC, Vial C, Delmont E, Viala K, Steck AJ, Magot A, Cauquil C, Zarea A, Echaniz-Laguna A, Iancu Ferfoglia R, Gueguen A, Magy L, Léger JM, Kuntzer T, Ferraud K, Lacour A, Camdessanché JP; Francophone anti-MAG cohort Group.

J Neurol Neurosurg Psychiatry. 2018 May;89(5):499-505. doi: 10.1136/jnnp-2017-316715. Epub 2017 Oct 25.

PMID:
29070644
15.

Mutation in the RRM2 domain of TDP-43 in Amyotrophic Lateral Sclerosis with rapid progression associated with ubiquitin positive aggregates in cultured motor neurons.

Maurel C, Madji-Hounoum B, Thepault RA, Marouillat S, Brulard C, Danel-Brunaud V, Camdessanche JP, Blasco H, Corcia P, Andres CR, Vourc'h P.

Amyotroph Lateral Scler Frontotemporal Degener. 2018 Feb;19(1-2):149-151. doi: 10.1080/21678421.2017.1349152. Epub 2017 Jul 13.

PMID:
28705014
16.

Paraneoplastic neuropathies.

Antoine JC, Camdessanché JP.

Curr Opin Neurol. 2017 Oct;30(5):513-520. doi: 10.1097/WCO.0000000000000475. Review.

PMID:
28682959
17.

Home care organization impacts patient management and survival in ALS.

Lavernhe S, Antoine JC, Court-Fortune I, Dimier N, Costes F, Lacour A, Camdessanché JP.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 Nov;18(7-8):562-568. doi: 10.1080/21678421.2017.1332076. Epub 2017 Jun 6.

PMID:
28585472
18.

Amyotrophic lateral sclerosis or not: Keys for the diagnosis.

Lenglet T, Camdessanché JP.

Rev Neurol (Paris). 2017 May;173(5):280-287. doi: 10.1016/j.neurol.2017.04.003. Epub 2017 Apr 28. Review.

PMID:
28461025
19.

Demyelinating polyradiculoneuropathy under combined BRAF/MEK inhibitors.

Devic P, Amini-Adle M, Camdessanché JP, Dalle S.

Eur J Cancer. 2017 Jun;78:103-104. doi: 10.1016/j.ejca.2017.03.018. Epub 2017 Apr 19. No abstract available.

PMID:
28432982
20.

Hereditary neuropathy with liability to pressure palsy in patients under 30 years old: Neurophysiological data and proposed electrodiagnostic criteria.

Robert-Varvat F, Jousserand G, Bouhour F, Vial C, Cintas P, Echaniz-Laguna A, Delmont E, Clavelou P, Chauplannaz G, Jomir L, Pereon Y, Leonard-Louis S, Manel V, Antoine JC, Lacour A, Camdessanche JP.

Muscle Nerve. 2018 Feb;57(2):217-221. doi: 10.1002/mus.25666. Epub 2017 Jun 11.

PMID:
28407266
21.

SOD1 mutation can mask C9orf72 abnormal expansion.

Corcia P, Blasco H, Besson G, Camdessanché JP, Pautot V, Beltran S, Couratier P, Andres C, Camu W, Vourc'h P.

Eur J Neurol. 2017 Apr;24(4):e24. doi: 10.1111/ene.13257. No abstract available.

PMID:
28322003
22.

Added value of electromyography in the diagnosis of myopathy: A consensus exercise.

Pugdahl K, Johnsen B, Tankisi H, Camdessanché JP, de Carvalho M, Fawcett PRW, Labarre-Vila A, Liguori R, Nix W, Schofield I, Fuglsang-Frederiksen A.

Clin Neurophysiol. 2017 May;128(5):697-701. doi: 10.1016/j.clinph.2017.02.001. Epub 2017 Feb 15.

PMID:
28315611
23.

Effectiveness of mycophenolate mofetil as first-line therapy in AQP4-IgG, MOG-IgG, and seronegative neuromyelitis optica spectrum disorders.

Montcuquet A, Collongues N, Papeix C, Zephir H, Audoin B, Laplaud D, Bourre B, Brochet B, Camdessanche JP, Labauge P, Moreau T, Brassat D, Stankoff B, de Seze J, Vukusic S, Marignier R; NOMADMUS study group and the Observatoire Français de la Sclérose en Plaques (OFSEP).

Mult Scler. 2017 Sep;23(10):1377-1384. doi: 10.1177/1352458516678474. Epub 2016 Nov 25.

PMID:
27885065
24.

Foreword.

Eymard B, Camdessanché JP.

Rev Neurol (Paris). 2016 Oct;172(10):537-538. doi: 10.1016/j.neurol.2016.09.006. No abstract available.

PMID:
27725097
25.

Determination of normal values for an isocapnic hyperpnea endurance test in healthy individuals.

Vincent M, Court-Fortune I, Brun C, Camdessanché JP, Vergès S, Costes F.

Respir Physiol Neurobiol. 2016 Aug;230:5-10. doi: 10.1016/j.resp.2016.04.007. Epub 2016 Apr 30.

PMID:
27141852
26.

Unusual association of amyotrophic lateral sclerosis and myasthenia gravis: A dysregulation of the adaptive immune system?

Del Mar Amador M, Vandenberghe N, Berhoune N, Camdessanché JP, Gronier S, Delmont E, Desnuelle C, Cintas P, Pittion S, Louis S, Demeret S, Lenglet T, Meininger V, Salachas F, Pradat PF, Bruneteau G.

Neuromuscul Disord. 2016 Jun;26(6):342-6. doi: 10.1016/j.nmd.2016.03.004. Epub 2016 Mar 29.

PMID:
27102004
27.

Genetic analysis of CHCHD10 in French familial amyotrophic lateral sclerosis patients.

Teyssou E, Chartier L, Albert M, Bouscary A, Antoine JC, Camdessanché JP, Rotolo F, Couratier P, Salachas F, Seilhean D, Millecamps S.

Neurobiol Aging. 2016 Jun;42:218.e1-3. doi: 10.1016/j.neurobiolaging.2016.03.022. Epub 2016 Mar 24.

PMID:
27095681
28.

Clinical features and prognostic factors of spinal cord sarcoidosis: a multicenter observational study of 20 BIOPSY-PROVEN patients.

Durel CA, Marignier R, Maucort-Boulch D, Iwaz J, Berthoux E, Ruivard M, André M, Le Guenno G, Pérard L, Dufour JF, Turcu A, Antoine JC, Camdessanche JP, Delboy T, Sève P.

J Neurol. 2016 May;263(5):981-990. doi: 10.1007/s00415-016-8092-5. Epub 2016 Mar 23.

PMID:
27007482
29.

Evaluation of the application of the European guidelines for the diagnosis and clinical care of amyotrophic lateral sclerosis (ALS) patients in six French ALS centres.

Marin B, Beghi E, Vial C, Bernard E, Lautrette G, Clavelou P, Guy N, Lemasson G, Debruxelles S, Cintas P, Antoine JC, Camdessanche JP, Logroscino G, Preux PM, Couratier P; EURECALS consortium.

Eur J Neurol. 2016 Apr;23(4):787-95. doi: 10.1111/ene.12941. Epub 2016 Feb 1.

PMID:
26833536
30.

Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational study.

Barbin L, Rousseau C, Jousset N, Casey R, Debouverie M, Vukusic S, De Sèze J, Brassat D, Wiertlewski S, Brochet B, Pelletier J, Vermersch P, Edan G, Lebrun-Frenay C, Clavelou P, Thouvenot E, Camdessanché JP, Tourbah A, Stankoff B, Al Khedr A, Cabre P, Papeix C, Berger E, Heinzlef O, Debroucker T, Moreau T, Gout O, Bourre B, Créange A, Labauge P, Magy L, Defer G, Foucher Y, Laplaud DA; CFSEP and OFSEP groups.

Neurology. 2016 Feb 23;86(8):771-8. doi: 10.1212/WNL.0000000000002395. Epub 2016 Jan 29.

31.

Identifying a therapeutic window in acute and subacute inflammatory sensory neuronopathies.

Antoine JC, Robert-Varvat F, Maisonobe T, Créange A, Franques J, Mathis S, Delmont E, Kuntzer T, Lefaucheur JP, Pouget J, Viala K, Desnuelle C, Echaniz-Laguna A, Rotolo F, Camdessanché JP; French Neuromuscular Network FILNEMUS.

J Neurol Sci. 2016 Feb 15;361:187-91. doi: 10.1016/j.jns.2015.12.044. Epub 2015 Dec 29.

PMID:
26810539
32.

Visual Assessment of Age-Related White Matter Hyperintensities Using FLAIR Images at 3 T: Inter- and Intra-Rater Agreement.

Boutet C, Rouffiange-Leclair L, Schneider F, Camdessanché JP, Antoine JC, Barral FG.

Neurodegener Dis. 2016;16(3-4):279-83. doi: 10.1159/000441420. Epub 2015 Dec 9.

PMID:
26646220
33.

Peripheral small fiber dysfunction and neuropathic pain in patients with Morvan syndrome.

Laurencin C, André-Obadia N, Camdessanché JP, Mauguière F, Ong E, Vukusic S, Peter-Derex L, Meyronet D, Bouhour F, Vial C, Ducray F, Honnorat J, Petiot P.

Neurology. 2015 Dec 8;85(23):2076-8. doi: 10.1212/WNL.0000000000002037. Epub 2015 Sep 23. No abstract available.

PMID:
26400578
34.

[Review of the current use of rituximab during 4 years in a French university hospital].

Reynaud Q, Killian M, Robles A, Mounsef F, Camdessanché JP, Mariat C, Cathébras P.

Rev Med Interne. 2015 Dec;36(12):800-12. doi: 10.1016/j.revmed.2015.06.005. Epub 2015 Aug 28. French.

PMID:
26318843
35.

Excess Mortality in Patients with Multiple Sclerosis Starts at 20 Years from Clinical Onset: Data from a Large-Scale French Observational Study.

Leray E, Vukusic S, Debouverie M, Clanet M, Brochet B, de Sèze J, Zéphir H, Defer G, Lebrun-Frenay C, Moreau T, Clavelou P, Pelletier J, Berger E, Cabre P, Camdessanché JP, Kalson-Ray S, Confavreux C, Edan G.

PLoS One. 2015 Jul 6;10(7):e0132033. doi: 10.1371/journal.pone.0132033. eCollection 2015.

36.

Somatosensory evoked potentials in the assessment of peripheral neuropathies: Commented results of a survey among French-speaking practitioners and recommendations for practice.

Morizot-Koutlidis R, André-Obadia N, Antoine JC, Attarian S, Ayache SS, Azabou E, Benaderette S, Camdessanché JP, Cassereau J, Convers P, d'Anglejean J, Delval A, Durand MC, Etard O, Fayet G, Fournier E, Franques J, Gavaret M, Guehl D, Guerit JM, Krim E, Kubis N, Lacour A, Lozeron P, Mauguière F, Merle PE, Mesrati F, Mutschler V, Nicolas G, Nordine T, Pautot V, Péréon Y, Petiot P, Pouget J, Praline J, Salhi H, Trébuchon A, Tyvaert L, Vial C, Zola JM, Zyss J, Lefaucheur JP.

Neurophysiol Clin. 2015 May;45(2):131-42. doi: 10.1016/j.neucli.2015.04.001. Epub 2015 May 6.

PMID:
25957985
37.

Vincristine-induced neuropathy: Atypical electrophysiological patterns in children.

Courtemanche H, Magot A, Ollivier Y, Rialland F, Leclair-Visonneau L, Fayet G, Camdessanché JP, Péréon Y.

Muscle Nerve. 2015 Dec;52(6):981-5. doi: 10.1002/mus.24647. Epub 2015 Sep 12.

PMID:
25758843
38.

Antifibroblast growth factor receptor 3 antibodies identify a subgroup of patients with sensory neuropathy.

Antoine JC, Boutahar N, Lassablière F, Reynaud E, Ferraud K, Rogemond V, Paul S, Honnorat J, Camdessanché JP.

J Neurol Neurosurg Psychiatry. 2015 Dec;86(12):1347-55. doi: 10.1136/jnnp-2014-309730. Epub 2015 Jan 27.

PMID:
25628376
39.

Adult-onset genetic leukoencephalopathies: a MRI pattern-based approach in a comprehensive study of 154 patients.

Ayrignac X, Carra-Dalliere C, Menjot de Champfleur N, Denier C, Aubourg P, Bellesme C, Castelnovo G, Pelletier J, Audoin B, Kaphan E, de Seze J, Collongues N, Blanc F, Chanson JB, Magnin E, Berger E, Vukusic S, Durand-Dubief F, Camdessanche JP, Cohen M, Lebrun-Frenay C, Brassat D, Clanet M, Vermersch P, Zephir H, Outteryck O, Wiertlewski S, Laplaud DA, Ouallet JC, Brochet B, Goizet C, Debouverie M, Pittion S, Edan G, Deburghgraeve V, Le Page E, Verny C, Amati-Bonneau P, Bonneau D, Hannequin D, Guyant-Maréchal L, Derache N, Defer GL, Moreau T, Giroud M, Guennoc AM, Clavelou P, Taithe F, Mathis S, Neau JP, Magy L, Devoize JL, Bataillard M, Masliah-Planchon J, Dorboz I, Tournier-Lasserve E, Levade T, Boespflug Tanguy O, Labauge P.

Brain. 2015 Feb;138(Pt 2):284-92. doi: 10.1093/brain/awu353. Epub 2014 Dec 19.

PMID:
25527826
40.

Pathophysiology and biomarkers in chronic inflammatory demyelinating polyradiculoneuropathies.

Svahn J, Antoine JC, Camdessanché JP.

Rev Neurol (Paris). 2014 Dec;170(12):808-17. doi: 10.1016/j.neurol.2014.10.009. Epub 2014 Nov 6. Review.

PMID:
25459126
41.

Is there a paraneoplastic ALS?

Corcia P, Gordon PH, Camdessanche JP.

Amyotroph Lateral Scler Frontotemporal Degener. 2015 Jun;16(3-4):252-7. doi: 10.3109/21678421.2014.965178. Epub 2014 Oct 6. Review.

PMID:
25285651
42.

[Sensory neuronopathy: diagnostic strategy].

Camdessanché JP, Antoine JC.

Presse Med. 2014 Nov;43(11):1185-8. doi: 10.1016/j.lpm.2014.02.034. Epub 2014 Sep 4. French.

PMID:
25201592
43.

Acute neurological worsening after Rituximab treatment in patients with anti-MAG neuropathy.

Sala E, Robert-Varvat F, Paul S, Camdessanché JP, Antoine JC.

J Neurol Sci. 2014 Oct 15;345(1-2):224-7. doi: 10.1016/j.jns.2014.07.055. Epub 2014 Aug 2.

PMID:
25115501
44.

Testing the validity of a set of diagnostic criteria for sensory neuronopathies: a francophone collaborative study.

Antoine JC, Robert-Varvat F, Maisonobe T, Créange A, Franques J, Mathis S, Delmont E, Kuntzer T, Lefaucheur JP, Pouget J, Viala K, Desnuelle C, Echaniz-Laguna A, Rotolo F, Camdessanché JP; French CIDP study group.

J Neurol. 2014 Nov;261(11):2093-100. doi: 10.1007/s00415-014-7423-7. Epub 2014 Aug 10.

PMID:
25108558
45.

Heterozygous CLCN1 mutations can modulate phenotype in sodium channel myotonia.

Furby A, Vicart S, Camdessanché JP, Fournier E, Chabrier S, Lagrue E, Paricio C, Blondy P, Touraine R, Sternberg D, Fontaine B.

Neuromuscul Disord. 2014 Nov;24(11):953-9. doi: 10.1016/j.nmd.2014.06.439. Epub 2014 Jul 2.

PMID:
25088311
46.

[Neurophysiological investigations in amyotrophic lateral sclerosis].

Camdessanché JP, Lenglet T.

Presse Med. 2014 May;43(5):563-8. doi: 10.1016/j.lpm.2014.03.003. Epub 2014 Apr 29. French.

PMID:
24785142
47.

Switching from natalizumab to fingolimod in multiple sclerosis: a French prospective study.

Cohen M, Maillart E, Tourbah A, De Sèze J, Vukusic S, Brassat D, Anne O, Wiertlewski S, Camu W, Courtois S, Ruet A, Debouverie M, Le Page E, Casez O, Heinzlef O, Stankoff B, Bourre B, Castelnovo G, Rico A, Berger E, Camdessanche JP, Defer G, Clavelou P, Al Khedr A, Zephir H, Fromont A, Papeix C, Brochet B, Pelletier J, Lebrun C; Club Francophone de la Sclérose en Plaques Investigators.

JAMA Neurol. 2014 Apr;71(4):436-41. doi: 10.1001/jamaneurol.2013.6240.

PMID:
24566807
48.

Paraneoplastic disorders of the peripheral nervous system.

Antoine JC, Camdessanché JP.

Presse Med. 2013 Jun;42(6 Pt 2):e235-44. doi: 10.1016/j.lpm.2013.01.059. Epub 2013 Apr 19. Review.

PMID:
23608019
49.

Tetraparesia with areflexia revealing cerebral venous thrombosis.

Exbrayat S, Epinat M, Atroun T, Camdessanche JP, Garnier P, Varvat J.

Rev Neurol (Paris). 2013 Mar;169(3):280-1. doi: 10.1016/j.neurol.2012.09.011. Epub 2013 Feb 6. No abstract available.

PMID:
23394852
50.

Absence of airway secretion accumulation predicts tolerance of noninvasive ventilation in subjects with amyotrophic lateral sclerosis.

Vandenberghe N, Vallet AE, Petitjean T, Le Cam P, Peysson S, Guérin C, Dailler F, Jay S, Cadiergue V, Bouhour F, Court-Fortune I, Camdessanche JP, Antoine JC, Philit F, Beuret P, Bin-Dorel S, Vial C, Broussolle E.

Respir Care. 2013 Sep;58(9):1424-32. doi: 10.4187/respcare.02103. Epub 2013 Jan 15.

Supplemental Content

Loading ...
Support Center